Products

Tirzepatide is a pharmaceutical compound initially developed for the management of type 2 diabetes but has also shown significant potential as a weight loss treatment. As a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, it acts on multiple pathways to regulate glucose metabolism and appetite control. Clinical trials evaluating tirzepatide for weight loss have demonstrated notable reductions in body weight, often exceeding those observed with standard diabetes treatments alone. Its mechanism of action includes appetite suppression, reduced food intake, and increased energy expenditure, making it a promising option for individuals struggling with obesity or overweight conditions. If approved for weight loss, tirzepatide could provide a valuable therapeutic option in the fight against obesity-related health complications.

• 2.5mg=$225/month

• 5mg=$285/month

• 7.5mg=$430/month

• 10mg=$575/month

• 12.5mg=$720/month

• 15mg= $865/ month